Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$510,929
-$394,651 QoQ
Shares Held
21,218
-34.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,745
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $15,181,531 across 16 Drug Manufacturers - General names. PFE ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,744 | $5,690,096 | |
| 2 | ABBV |
AbbVie Inc.
|
13,684 | $3,443,441 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,850 | $1,265,725 | |
| 4 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 5 | JNJ |
Johnson & Johnson
|
4,515 | $1,146,674 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,971 | $754,376 | |
| 7 | PFE |
Pfizer Inc
This page
|
21,218 | $510,929 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,810 | $334,772 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $510,929 | 21,218 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $905,580 | 32,250 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $704,321 | 28,286 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $653,842 | 25,661 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $450,839 | 18,599 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $610,187 | 24,080 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $673,835 | 25,399 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $814,603 | 28,148 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $704,676 | 25,185 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $688,893 | 24,825 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,112,503 | 38,642 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,248,030 | 67,773 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,274,966 | 62,022 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $3,307,044 | 81,055 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $3,786,533 | 73,898 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $3,215,659 | 73,484 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $3,297,112 | 62,886 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $3,060,228 | 59,112 | Shares | Sole | 2023-12-13 | |
| 2021-12-31 | $2,400,441 | 40,651 | Shares | Sole | 2023-12-13 | |
| 2021-09-30 | $1,681,260 | 39,090 | Shares | Sole | 2023-12-13 | |
| 2021-06-30 | $459,699 | 11,739 | Shares | Sole | 2023-12-13 | |
| 2021-03-31 | $277,376 | 7,656 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $238,491 | 6,479 | Shares | Sole | 2021-05-17 | |
| 2020-03-31 | $235,954 | 7,229 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||